CoChat

UBE1L is a retinoid target that triggers PML/RARα degradation and apoptosis in acute promyelocytic leukemia

Open access
Kitareewan, Sutisak, Pitha-Rowe, Ian, Sekula, David, Lowrey, Christopher H., Nemeth, Michael J., Golub, Todd R., Freemantle, Sarah J., Dmitrovsky, Ethan · 2002 · Proceedings of the National Academy of Sciences

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Abstract

All - trans -retinoic acid (RA) treatment induces remissions in acute promyelocytic leukemia (APL) cases expressing the t(15;17) product, promyelocytic leukemia (PML)/RA receptor α (RARα). Microarray analyses previously revealed induction of UBE1L (ubiquitin-activating enzyme E1-like) after RA treatment of NB4 APL cells. We report here that this occurs within 3 h in RA-sensitive but not RA-resistant APL cells, implicating UBE1L as a direct retinoid target. A 1.3-kb fragment of the UBE1L promoter was capable of mediating transcriptional response to RA in a retinoid receptor-selective manner. PML/RARα, a repressor of RA target genes, abolished this UBE1L promoter activity. A hallmark of retinoid response in APL is the proteasome-dependent PML/RARα degradation. UBE1L transfection triggered PML/RARα degradation, but transfection of a truncated UBE1L or E1 did not cause this degradation. A tight link was shown between UBE1L induction and PML/RARα degradation. Notably, retroviral expression of UBE1L rapidly induced apoptosis in NB4 APL cells, but not in cells lacking PML/RARα expression. UBE1L has been implicated directly in retinoid effects in APL and may be targeted for repression by PML/RARα. UBE1L is proposed as a direct pharmacological target that overcomes oncogenic effects of PML/RARα by triggering its degradation and signaling apoptosis in APL cells.

Overview

Integrity signals

Registry

Crossref · 10.1073/pnas.052011299

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 34 references

Research works printed but not linked: 5

  1. H Yoshida, K Kitamura, K Tanaka, S Omura, T Miyazaki, T Hachiya, R Ohno, T Naoe Cancer Res 56, 2945–2948 (1996).
  2. C Nervi, F F Ferrara, M Fanelli, M R Rippo, B Tomassoni, P F Ferrucci, M Ruthardt, V Gelmetti, C Gambaeorti-Passerini, D Diverio, et al. Blood 92, 2244–2251 (1998).
  3. T A Stadheim, H Xiao, A Eastman Cancer Res 61, 1533–1540 (2001).
  4. B Carritt, K Kok, A van den Berg, J Osinga, A Pilz, R M W Hofstra, M B Davis, A Y van der Veen, P H Rabbitts, K Gulati, C H C M Buys Cancer Res 52, 1536–1541 (1992).
  5. 10.1002/(SICI)1097-0215(20000315)85:6<871::AID-IJC22>3.0.CO;2-O · doi:10.1002/(sici)1097-0215(20000315)85:6<871::aid-ijc22>3.0.co;2-o

Cited by

See all 117

Metadata

Authors
Kitareewan, S., Pitha-Rowe, I., Sekula, D., Lowrey, C. H., Nemeth, M. J., Golub, T. R., Freemantle, S. J., & Dmitrovsky, E.
Affiliations
  • Dartmouth College (US)
  • Departments of Pharmacology and Toxicology and Medicine, and Norris Cotton Cancer Center, Dartmouth Medical School, Hanover, NH 03755; Dana Farber Cancer Institute, Boston, MA 02115; and Whitehead Institute for Biomedical Research, Cambridge, MA 02139
Venue
Proceedings of the National Academy of Sciences
Published
2002-03-12
Volume
99
Issue
6
Pages
3806-3811
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W1989252518
Cited by
117
References
32
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 6 · 2018: 5 · 2017: 7 · 2016: 1 · 2015: 7 · 2014: 4 · 2013: 3 · 2012: 4
FWCI
3.22
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Heart, Lung, and Blood Institute (R01HL052243)
  • National Cancer Institute (R01CA062275, R01CA087546)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
Keywords
UBE1L, PML-RARα, acute promyelocytic leukemia, all-trans retinoic acid, protein degradation, apoptosis, E1 ubiquitin-activating enzyme, proteasome, transcriptional repression, NB4 cells, retinoid resistance
MeSH terms
Animals, Cell Differentiation, Cell Line, Cricetinae, Humans, Ligases, Neoplasm Proteins, Protein Processing, Post-Translational, RNA, Messenger, Transfection, Tretinoin, Tumor Cells, Cultured, Blotting, Western, Leukemia, Promyelocytic, Acute, Oncogene Proteins, Fusion, Up-Regulation, Apoptosis, Genes, Reporter, Ubiquitin-Activating Enzymes, Ubiquitin-Protein Ligases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: UBE1L is a retinoid target that triggers PML/RARα degradation and apoptosis in acute promyelocytic leukemia. https://app.cochat.ai/papers/10.1073/pnas.052011299
The paper
Kitareewan, S., Pitha-Rowe, I., Sekula, D., Lowrey, C. H., Nemeth, M. J., Golub, T. R., Freemantle, S. J., & Dmitrovsky, E. (2002). UBE1L is a retinoid target that triggers PML/RARα degradation and apoptosis in acute promyelocytic leukemia. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.052011299

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.